- Home
- HGTY vs KOD Comparison
HGTY vs KOD Comparison
Compare HGTY & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HGTY | KOD |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HGTY | KOD |
|---|---|---|
| Price | $12.65 | $27.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $14.00 | ★ $26.57 |
| AVG Volume (30 Days) | 107.8K | ★ 1.1M |
| Earning Date | 03-03-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 241.11 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,360,017,000.00 | N/A |
| Revenue This Year | $18.41 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.18 | ★ N/A |
| Revenue Growth | ★ 17.92 | N/A |
| 52 Week Low | $8.03 | $1.92 |
| 52 Week High | $14.00 | $31.18 |
Technical Indicators
Market Signals| Indicator | HGTY | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 53.49 |
| Support Level | $12.50 | $26.32 |
| Resistance Level | $12.93 | $29.38 |
| Average True Range (ATR) | 0.40 | 2.08 |
| MACD | -0.09 | -0.24 |
| Stochastic Oscillator | 8.00 | 53.69 |
Price Performance
Historical ComparisonAbout HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.